LifeStance Health (LFST) Liabilities and Shareholders Equity (2021 - 2025)
LifeStance Health (LFST) has disclosed Liabilities and Shareholders Equity for 5 consecutive years, with $2.2 billion as the latest value for Q4 2025.
- On a quarterly basis, Liabilities and Shareholders Equity rose 4.04% to $2.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $8.6 billion, a 1.8% increase, with the full-year FY2025 number at $2.2 billion, up 4.04% from a year prior.
- Liabilities and Shareholders Equity was $2.2 billion for Q4 2025 at LifeStance Health, up from $2.1 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.2 billion in Q4 2025 to a low of $1.9 billion in Q2 2021.
- A 5-year average of $2.1 billion and a median of $2.1 billion in 2023 define the central range for Liabilities and Shareholders Equity.
- Peak YoY movement for Liabilities and Shareholders Equity: grew 12.8% in 2022, then decreased 3.09% in 2024.
- LifeStance Health's Liabilities and Shareholders Equity stood at $1.9 billion in 2021, then increased by 12.8% to $2.2 billion in 2022, then decreased by 2.94% to $2.1 billion in 2023, then rose by 0.39% to $2.1 billion in 2024, then rose by 4.04% to $2.2 billion in 2025.
- Per Business Quant, the three most recent readings for LFST's Liabilities and Shareholders Equity are $2.2 billion (Q4 2025), $2.1 billion (Q3 2025), and $2.1 billion (Q2 2025).